Cafepharma Today

January 31 2025 - AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

U.S. Drug Sales Projected to Decline This Year
WSJ Online
Thursday, April 23, 2009 - 9:50am
tags:
drug sales
FDA Calendar Updates: Diabetes
Seeking Alpha
Thursday, April 23, 2009 - 9:48am
tags:
FDA, diabetes, Bristol-Myers Squibb, AstraZeneca, Onglyza, alogliptin, Takeda, Novo Nordisk, Victoza
Solvay: Yes, we're reviewing our strategies
Fierce Pharma
Thursday, April 23, 2009 - 9:27am
tags:
Solvay
Gilead Sciences: A Biotech No More
Seeking Alpha
Thursday, April 23, 2009 - 9:26am
tags:
Gilead Sciences, biotech
Pay for Performance for Prescription Drugs (Or Maybe Not)
WSJ Online
Thursday, April 23, 2009 - 9:22am
tags:
Januvia, Cigna, Merck, diabetes
Teva acquisition rumor pushes Watson trade
Globes,Israel
Thursday, April 23, 2009 - 8:31am
tags:
Teva Pharmaceuticals, Watson Pharmaceuticals, buyouts
Bristol-Myers, AstraZeneca drug approval delayed
Marketwatch
Thursday, April 23, 2009 - 8:26am
tags:
Bristol-Myers Squibb, FDA, AstraZeneca, Onglyza, diabetes
Sanofi-Aventis CEO: China key for future growth
Yahoo/AP
Thursday, April 23, 2009 - 6:49am
tags:
China, Pharma CEOs, Sanofi, Chris Viehbacher
Novartis posts 14 percent drop in 1Q profit
Yahoo/AP
Thursday, April 23, 2009 - 6:48am
tags:
Novartis, earnings
Icahn, Amylin fail to on settlement in proxy fight
Yahoo/AP
Wednesday, April 22, 2009 - 9:14pm
tags:
Carl Icahn, Amylin, Eli Lilly
Lilly: Court blocks Teva's generic Evista
Marketwatch
Wednesday, April 22, 2009 - 9:12pm
tags:
Teva Pharmaceuticals, Eli Lilly, generics, Evista
Baxter A Healthy Healthcare Holding
Investopedia
Wednesday, April 22, 2009 - 5:12pm
tags:
Baxter International
Report: Drug sales to fall in US, slow elsewhere
Yahoo/AP
Wednesday, April 22, 2009 - 4:08pm
tags:
drug sales
Official: FDA to OK Plan B for 17-year-olds
Google/AP
Wednesday, April 22, 2009 - 3:50pm
tags:
FDA, birth control, Plan B contraceptive, Teva Pharmaceuticals
Illumina shares fall following 1Q results
Yahoo/AP
Wednesday, April 22, 2009 - 3:42pm
tags:
Illumina, earnings
5-Star Stocks Poised to Pop: Forest Labs
Motley Fool
Wednesday, April 22, 2009 - 3:31pm
tags:
Forest Labs
Does Avastin Trial Mean Roche Paid Too Much for Genentech?
WSJ Online
Wednesday, April 22, 2009 - 11:27am
tags:
Roche, cancer, Genentech, drug trials, Avastin
Elan CEO says favors big pharma tie-up
Reuters
Wednesday, April 22, 2009 - 11:26am
tags:
Elan, M&A, Kelly Martin
Amylin: A Discounted Option on Byetta's Outcome
Seeking Alpha
Wednesday, April 22, 2009 - 11:25am
tags:
Amylin, diabetes, Byetta
Amgen Earnings: This May Hurt
TheStreet.com
Wednesday, April 22, 2009 - 11:22am
tags:
Amgen, earnings

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information